NeuroOne Medical Technologies NMTC · USD
Health Care · US listing · 🇺🇸 United States
0.89
+0.71%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About NeuroOne Medical Technologies
From its filings with the US Securities and Exchange Commission
NeuroOne Medical Technologies is based in Eden Prairie, Minnesota and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker NMTC. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 30 September 2025, it reported revenue of $9.1m and a net loss of $3.6m. At that date it held total assets of $10.8m and shareholders' equity of $7.1m.
Evo® Cortical: Cortical or subdural electrodes are used in intracranial electroencephalography (iEEG) surgeries to monitor, record and stimulate the surface of the brain for less than 30 days. Our Evo cortical electrode portfolio consists of various contact configurations of strip and grid electrodes.
Evo sEEG: Evo® sEEG Electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. Federal (USA) law restricts this device to sale by or on the order of a physician. Evo sEEG enhances the ability to identify the right foci zones to determine the best intervention for patients.
OneRF® Brain Ablation System: Our OneRF Brain Ablation System is indicated for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures. It provides bedside monitoring, mapping and ablation using the same device, giving physicians a less invasive, potentially safer way to gain improved bedside clarity of the therapeutic window for an epilepsy patient with the possibility of seizure reduction or freedom.
Quoted from its 10-K, filed 17 Dec 2025. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 9 Nov 2012
- Employees
- 15
- Website
- nmtc1.com ↗
- Head office
- 7599 ANAGRAM DR, EDEN PRAIRIE, MN, 55344
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Paul BuckmanIndependent Chairman of the Board$169,000
- Mr. David RosaPresident, Chief Executive Officer, Director, since 2017$2.0m
- Mr. Mark ChristiansonCo-Founder, Business Development Director, Medical Sales Liaison
- Mr. Ronald McclurgChief Financial Officer$598,553
- Mr. Christopher VolkerChief Operating Officer$712,147
- Mr. Steve MertensChief Technology Officer$457,714
- Ms. Emily JohnsGeneral Counsel, Corporate Secretary
- Mr. Edward AndrleIndependent Director$119,000
- Mr. Jeffrey MathiesenIndependent Director$120,500
- Mr. Chris DonovanInvestor Relations, since 2024
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Thin film electrode technology for cEEG and sEEG recording solutions.
- 15 full-time employees focused on medical technology development.
- IPO on 9 November 2012 for capital growth.
Weaknesses
- Limited employee count of 15 in a competitive Health Care sector.
- No mention of specific product sales or revenue figures.
- Headquarters in Eden Prairie, Minnesota, a small city.
Opportunities
- Applications of technology with artificial intelligence in medical solutions.
- Expansion into epilepsy and Parkinson's disease treatment markets.
- Development of cortical, sheet, and depth electrode technology.
Threats
- Competition from larger Health Care companies in medical technology.
- Potential regulatory challenges in the Health Care industry.
- Dependence on medical technology adoption rates.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.